期刊
JOURNAL OF NANOBIOTECHNOLOGY
卷 20, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12951-022-01324-w
关键词
Interstitial radiotherapy; Biomimetic radiosensitizers; Radiogenetics; PD-L1 upregulation; Hypoxic and immunosuppressive microenvironment
资金
- National Natural Science Foundation of China [82071956, 82022033]
- Clinical Research Plan of SHDC [2020CR4065]
- National Key Research and Development Program of China [2016YFC0104303]
- Shanghai Rising-Star Program [19QA1406800]
- Shanghai Talent Development Fund [2019040]
By designing Mn-based IRT radiosensitizers, local interstitial radiotherapy can be enhanced to address the insufficient systematic immune responses and inhibit tumor metastasis by remodeling the tumor microenvironment and activating immune responses.
Background: Similar to other local therapeutic methods, local interstitial radiotherapy (IRT) also suffers from insufficient systematic immune activation, resulting in tumor metastasis. Results: Mn-based IRT radiosensitizers consisting of I-131, MnO2 and bovine serum albumin (BSA) (I-131-MnO2-BSA) were engineered. Such Mn-based IRT radiosensitizers successfully unlocked radiogenetics to magnify systematic immune responses of local IRT via remodeling hypoxic and immunosuppressive microenvironments and resist tumor metastasis. The MnO2 in I-131-MnO2-BSA caused decomposition of H2O2 enriched in tumors to generate O-2 for alleviating hypoxic microenvironment and removing tumor resistances to IRT. Concurrently, hypoxia mitigation by such radiosensitizers-unlocked radiogenetics can effectively remodel immunosuppressive microenvironment associated with regulatory T (Treg) cells and tumor-associated macrophages (TAMs) infiltration inhibition to induce immunogenic cell death (ICD), which, along with hypoxia mitigation, activates systematic immune responses. More intriguingly, I-131-MnO2-BSA-enabled radiogenetics can upregulate PD-L1 expression, which allows anti-PD-L1-combined therapy to exert a robust antitumor effect on primary tumors and elicit memory effects to suppress metastatic tumors in both tumor models (4T1 and CT26). Conclusions: IRT radiosensitizer-unlocked radiogenetics and the corresponding design principle provide a general pathway to address the insufficient systematic immune responses of local IRT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据